companydata.dkEvaxion A/S: Financial statements 2012
CVR: 31762863
Evaxion A/S (CVR 31762863) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 1,374,684 and a net result of DKK 324,467. The profit margin was 23.6%. Equity amounted to DKK 119,323. The solvency ratio was 10.1%.
- Revenue
- 1,374,684 kr.
- Profit/Loss
- 324,467 kr.
- Equity
- 119,323 kr.
- Total Assets
- 1,177,525 kr.
How creditworthy is Evaxion A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2012
As of February 15, 2012, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of Evaxion A/S.
As of February 15, 2012, DKNF 387 ApS has stepped down as auditor of Evaxion A/S.
About Evaxion A/S
Evaxion A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named EVAXION BIOTECH A/S and EVAXION BIOTECH ApS. The management consists of Andreas Holm Mattsson, Thomas Frederik Schmidt and Helen Katrina Tayton-Martin. The company is owned by BNY (Nominees) Limited (as nominee of The Bank of New York Mellon). The company has 24 employees. In 2025, the company reported revenue of DKK 48,112,000 and a net result of DKK -51,489,000 compared with DKK -73,277,000 the year before. Equity amounted to DKK 108,250,000.